CRMD CorMedix Inc.
Nasdaq · SEC CIK 1410098 · EDGAR
- Bought, last 12 months
- $275.5K 1 purchases by 1 insiders
- Sold, last 12 months
- $2.64M 8 sales by 4 insiders
- Filings on record
- 125 since 2021-11-03, latest 2026-09-18 21:36
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| Dillione Janet | Dir | — | $1.55M |
| Lefkowitz Steven W | Dir | — | $475.2K |
| Todisco Joseph | CEO, Dir | — | $360.0K |
| Kaplan Myron | Dir | $275.5K | — |
| DUNTON ALAN W | Dir | — | $260.0K |
| Seckler Michael David | Chief Commercial Off | — | — |
| Zelnick Kaufman Beth | CLO | — | — |
| Duncan Gregory Scott | Dir | — | — |
| Blum Susan | CFO | — | — |
| Hurlburt Elizabeth | COO | — | — |
Transactions 120
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-18 | CRMD | Kaplan Myron | Dir | P - Purchase | $4.54 | +6,000 | 166.0K | +4% | +$27.2K | |
| A | 2023-05-18 | 2023-05-17 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $4.58 | +5,000 | 209.7K | +2% | +$22.9K |
| A | 2023-05-18 | 2023-05-17 | CRMD | Costa Paulo F | Dir | P - Purchase | $4.65 | +10.0K | 10.0K | New | +$46.5K |
| A | 2023-05-18 | 2023-05-17 | CRMD | Stewart Robert A | Dir | P - Purchase | $4.37 | +10.0K | 11.0K | +1,000% | +$43.7K |
| A | 2023-05-18 | 2023-05-17 | CRMD | DUNTON ALAN W | Dir | P - Purchase | $4.33 | +3,000 | 9,250 | +48% | +$13.0K |
| 2023-05-17 | 2023-05-17 | CRMD | DUNTON ALAN W | Dir | A - Grant | $4.33 | +3,000 | 9,250 | +48% | +$13.0K | |
| 2023-05-17 | 2023-05-17 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $4.58 | +5,000 | 209.7K | +2% | +$22.9K | |
| 2023-05-17 | 2023-05-17 | CRMD | Stewart Robert A | Dir | A - Grant | $4.37 | +10.0K | 11.0K | +1,000% | +$43.7K | |
| 2023-05-17 | 2023-05-17 | CRMD | Costa Paulo F | Dir | A - Grant | $4.65 | +10.0K | 10.0K | New | +$46.5K | |
| T | 2023-05-12 | 2023-05-10 | CRMD | Todisco Joseph | CEO, Dir | F - Tax | $5.30 | -37.4K | 204.7K | -15% | -$198.4K |
| 2022-11-16 | 2022-11-15 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $3.82 | +20.0K | 242.2K | +9% | +$76.4K | |
| 2022-08-25 | 2022-08-24 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $3.92 | +4,700 | 222.2K | +2% | +$18.4K | |
| 2022-05-18 | 2022-05-17 | CRMD | Kaplan Myron | Dir | P - Purchase | $3.78 | +5,000 | 160.0K | +3% | +$18.9K | |
| 2022-05-17 | 2022-05-16 | CRMD | Todisco Joseph | CEO, Dir | P - Purchase | $3.38 | +10.0K | 217.5K | +5% | +$33.8K | |
| D | 2022-05-12 | 2022-05-10 | CRMD | Todisco Joseph | CEO, Dir | A - Grant | $0.00 | +207.5K | 207.5K | New | $0 |
| M | 2021-12-29 | 2021-12-27 | CRMD | Kaplan Myron | Dir | G - Gift | $0.00 | -35.0K | 150.0K | -19% | $0 |
| 2021-12-07 | 2021-12-06 | CRMD | David Matthew T | CFO, Interim CEO | P - Purchase | $4.50 | +1,000 | 3,150 | +47% | +$4,500 | |
| 2021-12-07 | 2021-12-06 | CRMD | David Matthew T | CFO, Interim CEO | P - Purchase | $4.50 | +1,000 | 3,150 | +47% | +$4,500 | |
| 2021-11-19 | 2021-11-17 | CRMD | David Matthew T | CFO, Interim CEO | P - Purchase | $5.07 | +1,000 | 2,150 | +87% | +$5,070 | |
| 2021-11-19 | 2021-11-16 | CRMD | Kaplan Myron | Dir | P - Purchase | $5.14 | +10.0K | 175.0K | +6% | +$51.4K |
Purchase Sale Sale after option exercise All abbreviations